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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYHematopoietic stem cells (HSCs) originate from hemogenic endothelium within the aorta-gonad-mesonephros (AGM) region of the
mammalian embryo. The relationship between genetic circuits controlling stem cell genesis and multi-potency is not understood. A
Gata2 cis element (+9.5) enhances Gata2 expression in the AGM and induces the endothelial to HSC transition. We demonstrated that
GATA-2 rescuedhematopoiesis in +9.5/AGMs.AsG-protein-coupled receptors (GPCRs) are themost commontargets for FDA-approved
drugs, we analyzed the GPCR gene ensemble to identify GATA-2-regulated GPCRs. Of the 20 GATA-2-activated GPCR genes, four
were GATA-1-activated, and only Gpr65 expression resembled Gata2. Contrasting with the paradigm in which GATA-2-activated genes
promote hematopoietic stem and progenitor cell genesis/function, our mouse and zebrafish studies indicated that GPR65 suppressed
hematopoiesis. GPR65 established repressive chromatin at the +9.5 site, restricted occupancy by the activator Scl/TAL1, and repressed
Gata2 transcription. Thus, aGata2 cis element creates a GATA-2-GPCR circuit that limits positive regulators that promote hematopoiesis.INTRODUCTION
Establishment and maintenance of the adult hematopoiet-
ic system requires the generation of hematopoietic stem
cells (HSCs) from a unique endothelial cell (hemogenic)
in the aorta-gonad-mesonephros (AGM) region of the
mammalian embryo (Dzierzak and Speck, 2008). HSCs
develop in clusters that bud off from hemogenic endothe-
lium (Bertrand et al., 2010; Boisset et al., 2010), a process
termed endothelial to hematopoietic transition (EHT).
HSCs migrate to and colonize the fetal liver and, sub-
sequently, the bone marrow (Orkin and Zon, 2008).
Whereas major efforts have focused on defining regulatory
proteins/networks governing EHT, many questions remain
unanswered regarding the molecular constituents and
mechanisms.
Master regulatory transcription factors co-localize at cis
elements of target genes in hematopoietic stem and pro-
genitor cells (HSPCs) to establish genetic networks that
control hematopoiesis (Beck et al., 2013; Fujiwara et al.,
2009; May et al., 2013; Tripic et al., 2008; Wilson et al.,
2010; Wozniak et al., 2008; Yu et al., 2009). The combina-
torial mechanisms operating in hemogenic endothelium,
and the relationship between mechanisms governing
EHT and HSC multi-potency, are unclear. A shared compo-
nent of the mechanisms involves the transcription factor
GATA-2, which is required for definitive hematopoiesis
(Tsai et al., 1994). GATA-2 functions in hemogenic endo-368 Stem Cell Reports j Vol. 6 j 368–382 j March 8, 2016 j ª2016 The Authothelium to induce EHT and regulates HSC function (de
Pater et al., 2013; Gao et al., 2013; Johnson et al., 2012;
Ling et al., 2004; Rodrigues et al., 2005).
Since GATA-2 induces EHT, it is instructive to consider
factors/signals upstream of GATA-2. Deletion of a cis
element 9.5 kb downstream of the Gata2 promoter (+9.5)
in mice decreased Gata2 expression in AGM hemogenic
endothelium, deregulated genes encoding positive regula-
tors of hematopoiesis, and abrogated EHT (Gao et al.,
2013). Deletion of a cis element 77 kb upstream of the pro-
moter (77) reduced Gata2 expression in myelo-erythroid
progenitors and impaired progenitor function without
affecting EHT (Johnson et al., 2015). The defective HSC
generator of +9.5/ embryos depleted HSPCs in the
fetal liver and caused lethality at embryonic day 13–14
(E13–14) (Johnson et al., 2012). Since the +9.5 controls
Gata2 expression and EHT (Gao et al., 2013; Hsu et al.,
2013), and GATA-2 occupies the +9.5 (Fujiwara et al.,
2009; Grass et al., 2006), one aspect of the +9.5 mechanism
involves GATA-2-mediated positive autoregulation. Factors
implicated upstream of GATA-2 include bone morphoge-
netic protein 4 (Lugus et al., 2007; Maeno et al., 1996),
Notch signaling (Guiu et al., 2013; Robert-Moreno et al.,
2008), the Ets factor Etv2 (Liu et al., 2015), and themethyl-
cytosine dioxygenases Tet2/Tet3 (Li et al., 2015).
The Gata2 +9.5 site regulates a large gene cohort in he-
mogenic endothelium, and these genes do not parse into
a single pathway (Gao et al., 2013). The genes includers
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Figure 1. GATA-2 Expression in +9.5/ AGM Rescues CD31+c-KIT+ Hematopoietic and CD31+c-KIT Endothelial Cells
(A) AGM ex vivo retroviral infection and culture.
(B) Flow cytometric analysis of GFP+ cells within total live cells (6 litters: +9.5+/+-Empty [n = 8 embryos]; +9.5/-Empty [n = 4
embryos]; +9.5/-GATA-2 [n = 6 embryos]).
(C) RT-PCR analysis of Gata2 mRNA levels in FACS-sorted CD31+c-KIT and CD31+c-KIT+ cells (six litters: +9.5+/+-Empty [n = 8
embryos]; +9.5/-Empty [n = 4 embryos]; +9.5/-GATA-2 [n = 6 embryos]).
(D) Representative flow cytometric plots of CD31+c-KIT+ and CD31+c-KIT cell populations in infected AGMs after 96 hr of ex vivo culture.
(legend continued on next page)
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Runx1, Lyl1, andMpl, positivemediators of HSC generation
and/or function. The identification of vital constituents of
the +9.5-dependent genetic network will reveal how a cis
element triggers EHT. As GATA-2 lacks features that can
be leveraged for drug binding, identifying +9.5 network
components will reveal strategies to promote HSC genera-
tion/function for transplantation and inhibit leukemia
cell proliferation and survival.
The most common targets for drugs approved by the
Food and Drug Administration are GPCRs (Roth and
Kroeze, 2015). The GPCR family consists of 341 non-olfac-
tory receptors classified as rhodopsin, secretin, glutamate,
adhesion, and frizzled/taste2, based on sequence homol-
ogy (Lagerstrom and Schioth, 2008). CXCR4, a
rhodopsin-like GPCR, recognizes SDF-1/CXCL-12 and con-
trols HSPC survival, proliferation, migration, and engraft-
ment (Broxmeyer et al., 2005). CXCR4 antagonists are
used as mobilizing agents for stem cell transplantation.
The prostaglandin PGE2, which functions through a group
of related GPCRs (Sugimoto andNarumiya, 2007), expands
HSPCs (Goessling et al., 2011; Hoggatt et al., 2013; North
et al., 2007). We described +9.5-mediated upregulation of
Gpr56 expression (Gao et al., 2013). Loss-of-function
analyses indicated that GPR56 promotes EHT (Solaimani
Kartalaei et al., 2015) and contributes to HSCmaintenance
(Saito et al., 2013). Galpha(s)-mediated signaling controls
HSPC engraftment of bone marrow (Adams et al., 2009).
By profiling expression of the GPCR cohort in the AGM,
we discovered a subset of GATA-2-regulated GPCRs and a
GATA-2- and GATA-1-regulated cohort, including GPR65,
which suppresses AGM hematopoiesis. The +9.5 site, and
its regulated protein GATA-2, which positively regulate he-
matopoiesis, upregulated Gpr65 encoding a negative regu-
lator of hematopoiesis. These results provide evidence for
a GATA factor-GPCR type I incoherent feedforward loop
as a vital component of the genetic network that controls
HSPC generation and function.RESULTS
GATA-2 Expression in +9.5/ AGM Rescues
Hematopoiesis
Deletion of the +9.5 site reduced Gata2 expression in AGM
hemogenic endothelium and abrogated EHT (Gao et al.,
2013) (Figure 1A). These results suggest that factors/signals
conferring +9.5 activity control Gata2 expression, which
promotes EHT. In principle, the +9.5 might regulate other(E and F) Quantitation of flow cytometry data expressed as percenta
percentage of GFP+ cells in CD31+c-KIT and CD31+c-KIT+ cells (F)
embryos]; +9.5/-GATA-2 [n = 6 embryos]).
Error bars represent SEM. *p < 0.05; **p < 0.01; ***p < 0.001 (two-t
370 Stem Cell Reports j Vol. 6 j 368–382 j March 8, 2016 j ª2016 The Authogenes in cis or in trans that control EHT. To determine
whether the HSC generation defect of +9.5/ AGM results
from insufficient GATA-2 production, we tested whether
GATA-2 expression rescues the defect. E11.5mouse embryo
AGMs were infected with GATA-2-expressing retrovirus
(Figure 1A). After 96 hr of explant culture, we quantitated
endothelial and hematopoietic cell populations in infected
(GFP+) cells by flow cytometry using CD31 and c-KIT sur-
face markers. The infection efficiency was similar among
the three conditions (+9.5+/+-empty vector, +9.5/-empty
vector, +9.5/-GATA-2), as indicated by the indistinguish-
able percentage of GFP+ live cells (Figure 1B). GATA-2
expression restored Gata2 mRNA to the wild-type level in
CD31+c-KIT endothelial and CD31+c-KIT+ hematopoietic
cells (Figure 1C), and rescued both populations (Figures 1D
and 1E). Since the infected cells express GFP, the percentage
of GFP+ cells in each population increased in +9.5/ AGM
infected with GATA-2-expressing retrovirus (Figure 1F).
However, retroviral-mediated GATA-2 expression did not
rescue CD31+c-KITendothelial and CD31+c-KIT+ hemato-
poietic cell populations in the GFP cells (Figure S1). Thus,
the +9.5/AGMhematopoiesis defect resulted from insuf-
ficient GATA-2 production, is associated with reduced
CD31+c-KIT endothelial cells, and can be rectified by
restoring GATA-2.
To assess whether the GATA-2-rescued CD31+c-KIT+
hematopoietic cells are functional, we measured their
capacity to generate myelo-erythroid colonies in a colony-
forming unit (CFU) assay. After culturing retroviral-infected
AGMs for 96hr,GFP+CD31+c-KIT+ hematopoietic cells were
isolated by fluorescence-activated cell sorting (FACS) and
assayed for their capacity to generate BFU-E (erythroid
burst-forming units), CFU-GM (granulocyte, macrophage),
and CFU-GEMM (granulocyte, erythrocyte, monocyte/
macrophage, megakaryocyte) colonies. Whereas +9.5/
AGM failed to generate CFUs, GATA-2 expression in
the +9.5/ AGM induced CFUs comparable with +9.5+/+
AGM (Figure 2A). Quantification of colony types revealed
comparable numbers of rescued CFU-GM colonies in com-
parisonwithwild-typeAGM (Figure 2B). GATA-2 expression
induced BFU-E and CFU-GEMM colonies (Figure 2B). Col-
onies derived from wild-type and rescued samples were
morphologically indistinguishable (Figure 2C). Wright-Gi-
emsa staining of cells from colonies revealed normal
myeloid and erythroid cell generation from the GATA-2-
expressing +9.5/ AGM (Figure 2D). The GATA-2-induced
CD31+c-KIT+ hematopoietic cells exhibited qualitatively
and quantitatively normal activity.ge of CD31+c-KIT and CD31+c-KIT+ cells in GFP+ cells (E) and the
(6 litters: +9.5+/+-Empty [n = 8 embryos]; +9.5/-Empty [n = 4
ailed unpaired Student’s t test).
rs
Figure 2. Rescued CD31+c-KIT+ Cells
Exhibit Normal Colony-Forming Unit
Activity
(A and B) Quantitative analysis of colony-
forming activity of FACS-sorted CD31+
c-KIT+ cells (6 litters: +9.5+/+-Empty [n =
9 embryos]; +9.5/-Empty [n = 7 embryos];
+9.5/-GATA-2 [n = 10 embryos]).
(C) Representative BFU-E, CFU-GM, and
CFU-GEMM colonies from FACS-sorted
CD31+c-KIT+ cells. Scale bar, 2 mm.
(D) Representative images of Wright-Gi-
emsa-stained cells from colonies. Ery,
erythroblast; Mac, macrophage; My, myeloid
precursor; Neu, neutrophil. Scale bar, 40 mm.
Error bars represent SEM. *p < 0.05; **p <
0.01; ***p < 0.001 (two-tailed unpaired
Student’s t test).Global GPCR Analysis in the AGM: Discovery of a
GATA Factor-Regulated GPCR Cohort
The +9.5 site confersGata2 expression and establishes a ge-
netic network involving known HSC regulators and genes
not implicated in hematopoiesis (Gao et al., 2013). To
discover vital constituents of the network, especially those
with potential for modulation by small molecules/drugs,
we systematically analyzed the expression pattern of
non-olfactory GPCRs (Figure 3A). The human genome en-
codes greater than 800 GPCRs, which are categorized into
rhodopsin, secretin, glutamate, adhesion and frizzled/
taste2 families based on sequence homology; 341 are
distinct from the olfactory and taste GPCRs (LagerstromStemand Schioth, 2008; Roth and Kroeze, 2015). Using our
AGM RNA-sequencing (RNA-seq) data (Gao et al., 2013),
we parsed AGM-expressed GPCRs into the canonical cate-
gories: secretin, 5% (15); adhesion, 7% (22); glutamate,
5% (15); frizzled/taste2, 6% (20); and rhodopsin, 70%
(221) (Figure 3B).
To discover GPCRs that control HSC generation and/or
activity, we evaluated GPCR expression in the AGM. Of
the 314 GPCRs annotated by RNA-seq, 85 were expressed
at >5 transcripts per million (Figure 3C), a level
that can be validated with high frequency by real-time
RT-PCR. Of the 85 GPCRs, 20 were downregulated
in the +9.5/ AGM versus +9.5+/+ AGM (Figure 3D),Cell Reports j Vol. 6 j 368–382 j March 8, 2016 j ª2016 The Authors 371
indicating GATA-2-regulation. Using our previous microar-
raydataset (untreatedorb-estradiol-treatedG1E-ER-GATA-1
erythroid precursor cells) (DeVilbiss et al., 2013), we found
that four of the 20 GATA-2-regulated GPCRs were GATA-1-
regulated (Figure 3D). Our strategy refined the 314 non-ol-
factory, AGM-expressed GPCRs to yield Adora3, Gpr65,
Ltb4r1, and P2ry1, which are GATA-2- and GATA-1-
regulated.
A GATA Factor-GPCR Incoherent Feedforward Loop
Suppresses AGM Hematopoiesis
As shared gene expression patterns can infer functional in-
terconnectivity, we comparedAdora3,Gpr65, Ltb4r1, P2ry1,
and Gata2 expression patterns in mouse cells and tissues.
Only Gpr65 resembled Gata2, both being expressed in
HSPCs and mast cells (Figure S2) (http://biogps.org). As
GATA-1 represses Gata2 during erythroid maturation via a
GATA switch, Gata2 expression declines upon erythroid
maturation. Mining the Erythron Database, which pro-
vides transcriptomics data during erythroid precursor cell
maturation into erythrocytes (Kingsley et al., 2013), re-
vealed Gata2 and Gpr65 repression upon erythroid differ-
entiation. Gpr65 was the only one of the four GPCR genes
to have a Gata2-like expression pattern (Figure 3E). To
further compare expression patterns, we quantitated
Gata2 and Gpr65 mRNA in G1E-ER-GATA-1 cells treated
with b-estradiol to induce erythroid maturation and in
FACS-sorted R1, R2, R3, and R4/5 fetal liver cell popula-
tions. Gpr65 and Gata2 were repressed during erythroid
maturation (Figures 3F and 3G). These correlations are
consistent with GATA-2 upregulating Gpr65 expression
in the AGM and may point to a functional link be-
tween GATA-2 and GPR65. Chromatin immunoprecipita-
tion (ChIP)-sequencing analysis in human (Figure 3H)
and mouse (Figure 3I) cells revealed GATA-2 occupancy at
Gpr65, suggesting that GATA-2 directly regulates Gpr65
transcription. Comparison of +9.5+/+ and +9.5/ AGM re-
vealed that reduced Gata2 expression in the +9.5/ AGM
decreased Gpr65 expression, and Gpr65 expression was un-
detectable in the yolk sac (Figure 3J). Previously, we demon-
strated that GATA-2 expression inmouse aortic endothelial
cells increases transcription of certain GATA-2 target genes
(Katsumura et al., 2014). In this system, GATA-2 increased
Gpr65 expression (Figure 3K), indicating that GATA-2 regu-
lates Gpr65 expression in multiple contexts. To analyze the
Gpr65 expression pattern in distinct cell types within the
AGM, we mined RNA-seq data obtained with FACS-sorted
endothelial cells, hemogenic endothelial cells, hematopoi-
etic cells, and HSCs from the AGM (Solaimani Kartalaei
et al., 2015). This analysis revealed that Gpr65 is detectable
in all cell types, and the levels are lower inHSCs (Figure 3L).
To test whether GPR65 controls hematopoiesis in the
AGM, we conducted a loss-of-function analysis using a372 Stem Cell Reports j Vol. 6 j 368–382 j March 8, 2016 j ª2016 The AuthoGpr65 short hairpin RNA (shRNA) retrovirus. E11.5 AGMs
were infected, and after culturing for 96 hr hematopoietic
cell populationswere quantitated byflowcytometry.Quan-
titation of GFP+ live cells indicated that control shRNA
(shLuc) and shGpr65 retroviruses had an indistinguishable
infection efficiency (Figures 4A and 4B). Gpr65 knockdown
reduced Gpr65 mRNA by 60%–70% (Figure 4C). While
downregulating Gpr65 did not alter CD31+c-KIT+ hemato-
poietic cells (Figures 4A and 4D), it increased CD31+c-
KIT+SCA1+ HSC-containing, multipotent hematopoietic
cells (Figures 4A and 4E). Retroviral-mediatedGpr65 shRNA
expression did not alter CD31+c-KIT+ hematopoietic cells
and CD31+c-KIT+SCA1+ HSC-containing cells in GFP cells
(Figure S3). These results indicate thatGPR65 suppresseshe-
matopoiesis in the AGM.
To assess whether Gpr65 activity to suppress hematopoi-
esis operates in other systems, we used a morpholino (MO)
targeting the Gpr65 translation start site (Gpr65_ATG MO)
to reduce Gpr65 expression in zebrafish embryos. The
Gpr65_ATG MO was injected into 1-cell stage embryos,
which were analyzed for expression of the HSPC markers
Runx1/cmyb using in situ hybridization (ISH) at 36 hr
post-fertilization. The Gpr65_ATG MO dose-dependently
increased expression of the HSPC markers Runx1/cmyb in
the embryos (Figures 4F and 4G). A second MO, which
blocks Gpr65 splicing (Gpr65_SP MO), yielded an identical
result; Gpr65 downregulation induced expression of the
HSPC markers Runx1/cmyb (Figure 4G). Thus, GPR65 sup-
presses hematopoiesis in mouse and zebrafish embryos.
shRNA and MO-based loss-of-function strategies may be
confounded by off-target effects. As an alternative strategy
we used a GPR65 antagonist, the lysosphingolipid galacto-
sylsphingosine (psychosine). Psychosine was initially pro-
posed to be a GPR65 agonist, based on the GPR65 require-
ment for psychosine-induced multi-nuclear cell formation
(Im et al., 2001). Subsequently, it was demonstrated that
GPR65 is a proton-sensing receptor and that psychosine
antagonizes GPR65 (Radu et al., 2005; Tobo et al., 2015;
Wang et al., 2004). We treated E11.5 AGMs with vehicle
or psychosine, and after 96 hr, hematopoietic cells were
quantitated by flow cytometry. While psychosine did not
alter CD31+c-KIT+ cells (Figures 5A and 5B), it increased
the CD31+c-KIT+SCA1+ cell population, which is known
to contain multipotent hematopoietic precursors (Figures
5A and 5C). In aggregate, the mouse and zebrafish studies
indicate that GPR65 is an endogenous suppressor of
hematopoiesis.
GPR65 Establishes Repressive Chromatin and Disrupts
an Activating Complex on a cis Element Required for
Gata2 Transcription
To elucidate the mechanism underlying GPR65 suppres-
sion of hematopoiesis, we considered whether GPR65rs
Figure 3. Global GPCR Analysis in the AGM
(A) Global GPCR analysis.
(B) Non-olfactory GPCRs (N = 314) were categorized into Secretin, Adhesion, Glutamate, Frizzled/Taste2, and Rhodopsin families based on
sequence homology.
(legend continued on next page)
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might downregulate key regulators of HSC generation/ac-
tivity. After knocking down GPR65, we isolated infected
CD31+c-KIT endothelial cells that give rise to HSCs.
Downregulating Gpr65 mRNA by 60%–70% increased
Gata2mRNA 2.9-fold (p = 0.03) and its downstream target
Runx1 mRNA 2.9-fold (p = 0.04) (Figure 5D). The knock-
down elevated Gata2 primary transcripts 3.9-fold (p =
0.04) (Figure 5E), indicating that GPR65 suppresses Gata2
transcription.
To determine whether GPR65 regulatesGata2 expression
in zebrafish, we analyzed Gata2 expression using ISH at
36 hr post-fertilization. Zebrafish have two Gata2 homo-
logs; Gata2b is enriched in hemogenic endothelium and
regulates HSPC emergence (Butko et al., 2015). Whereas
the majority of uninjected embryos exhibited broad stain-
ing in the AGM, there was no clear linear zone enriched in
hemogenic endothelium. However, Gpr65_ATG MO-in-
jected embryos exhibited the linear zone (Figure S4), sug-
gesting that GPR65 suppresses Gata2 expression in zebra-
fish embryos. Given that GATA-2 promotes HSC
emergence in the AGM and regulates HSC activity (de Pater
et al., 2013; Gao et al., 2013), we propose that GPR65 sup-
presses hematopoiesis by limiting Gata2 expression and
GATA-2 levels.
As Gpr65 is expressed in AGM endothelium and HSPCs,
we asked whether GPR65 represses Gata2 expression in
other contexts. Fetal liver hematopoietic precursors express
Gata2, and as GATA-1 rises upon erythroid maturation,
Gata2 is repressed (McIver et al., 2014). We isolated Lin
hematopoietic precursors from E14.5 fetal livers (McIver
et al., 2014) and tested whether reducing Gpr65 expression
with the Gpr65 shRNA retrovirus alters Gata2 expression.
Cells were expanded for 72 hr to increaseHSPCs, while sup-
pressing differentiation. Downregulating Gpr65 increased
the proerythroblast-enriched R2 population 1.9-fold (p =
0.0002) and reduced the R3 population (early and late baso-
philic erythroblasts) 1.6-fold (p = 0.0003) (Figure 6A).(C) Classification of 85 GPCRs expressed in the AGM (>5 transcripts p
(D) Bar graph depicting GATA-2-regulated genes from RNA-seq analysi
co-regulated by GATA-1 according to our prior microarray analysis of G
2013).
(E) Gata2, Adora3, Gpr65, Ltb4r1, and P2ry1 expression during erythr
roblast; P, proerythroblast; R, reticulocyte (http://www.cbil.upenn.e
(F) Time course of Gata2 and Gpr65 expression following b-estradiol
(G) RT-PCR analysis of Gata2 and Gpr65 in FACS-sorted R1, R2, R3, and
(H and I) ChIP signal map for Gpr65 in human CD34 cells (H) (Beck et a
cells (Li et al., 2011), and G1E cells (Trompouki et al., 2011) (I).
(J and K) RT-PCR analysis of Gata2 and Gpr65 mRNA in +9.5+/+ and
embryos]) and yolk sac (three litters: +9.5+/+ [n = 7 embryos]; +9.5/
independent experiments).
(L) RNA-seq of Gata2 and Gpr65 mRNA in FACS-sorted endothelial cells
and hematopoietic stem cells (HSC) from the AGM (Solaimani Kartala
Error bars represent SEM. *p < 0.05; ***p < 0.001 (two-tailed unpair
374 Stem Cell Reports j Vol. 6 j 368–382 j March 8, 2016 j ª2016 The AuthoIncreased R2 cells, concomitant with reduced R3 cells, sug-
gests that GPR65 promotes erythroid maturation. Downre-
gulatingGpr65mRNA by 70%–80%, which lowered GPR65
protein by 50%, increased Gata2mRNA and primary tran-
scripts 2.4 (p = 3.653 106) and 2.8-fold (p = 0.014), respec-
tively (Figures 6B and 6C). Western blot analysis of fetal
liver cells revealed that reducing GPR65 expression upregu-
lated GATA-2 (Figure 6D). Increased GATA-2 selectively
elevated GATA-2 target gene expression (Figure 6E). To
test whether increased Gata2 expression reflected a change
in cellularity, we used FACS to isolate the GATA-2-express-
ing R2 population and compared gene expression in
control and knockdown R2 cells. Gpr65 knockdown upre-
gulatedGata2mRNA 2.3-fold (p = 0.02), primary transcript
4.8-fold (p = 0.01), GATA-2 protein, and GATA-2 target
genes in FACS-sorted R2 cells (Figures 6F–6I). These results
indicate that GPR65 represses Gata2 in the AGM and fetal
liver. Since GATA-1 needs to repress Gata2 transcription
early in erythroid maturation, upregulated Gata2 expres-
sion caused by the Gpr65 knockdown would be expected
to increase immature R2 cells as observed (Figure 6A).
The +9.5 enhances Gata2 expression in the AGM and
fetal liver (Gao et al., 2013; Johnson et al., 2012; Sanalku-
mar et al., 2014). Deleting the +9.5 abrogated HSC gener-
ation in the AGM (Gao et al., 2013) and disrupted estab-
lishment of the HSPC compartment in the fetal liver
(Johnson et al., 2012). To determine whether increased
Gata2 transcription upon Gpr65 knockdown requires
the +9.5, we isolated Lin HSPCs from E14.5 + 9.5+/ fetal
livers and infected cells with Gpr65 shRNA retrovirus. Af-
ter 72 hr of expansion culture, allele-specific primers were
used to quantitate primary transcripts from wild-type and
mutant 9.5 alleles in fetal liver cells and FACS-purified R2
cells (Figure 6J). Gpr65 knockdown upregulated Gata2 pri-
mary transcripts from the wild-type, but not the +9.5
mutant, allele (Figure 6J), demonstrating importance of
the +9.5 for Gata2 transcription.er million) into five families.
s of +9.5+/+ and +9.5/ AGMs (Gao et al., 2013). Black bars, genes
1E-ER-GATA with or without b-estradiol treatment (DeVilbiss et al.,
opoiesis. B, basophilic erythroblast; O, polyorthochromatic eryth-
du/ErythronDB/).
treatment in G1E-ER-GATA cells (n = 3 independent experiments).
R4/5 populations from fetal liver (n = 3 independent experiments).
l., 2013), mouse HPC7 cells (Wilson et al., 2010), Lin bone marrow
+9.5/ AGM (5 litters: +9.5+/+ [n = 8 embryos]; +9.5/ [n = 6
 [n = 5 embryos]) (J), and MAE cells expressing GATA-2 (K) (n = 3
(EC), hemogenic endothelial cells (HEC), hematopoietic cells (HC),
ei et al., 2015).
ed Student’s t test).
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Figure 4. GPR65 Suppresses Hematopoiesis in the Mouse and Zebrafish AGM
(A) Representative flow cytometric plots of CD31+c-KIT+ and CD31+c-KIT+SCA1+ cell populations in control or Gpr65 shRNA-treated AGMs
after 96 hr of culture.
(B) Quantitation of GFP+ cells with total live cells (9 litters: shLuc [n = 22 embryos]; shGpr65 [n = 26 embryos]).
(C) RT-PCR analysis of Gpr65 mRNA levels in FACS-sorted GFP+ cells (6 litters: shLuc [n = 15 embryos]; shGpr65 [n = 15 embryos]).
(D and E) Analysis of flow cytometry data expressed as percentage of CD31+c-KIT+ (D) and CD31+c-KIT+Scal1+ (E) cells in GFP+ cells (D: 9
litters: shLuc [n = 22 embryos]; shGpr65 [n = 26 embryos]; E: 7 litters: shLuc [n = 18]; shGpr65 [n = 22]).
(F) Representative images of ISH with the HSPC markers Runx1/cMyb at 36 hr post-fertilization.
(G) Quantitation of ISH data expressed as percentage of embryos with high, medium, and low Runx1/cMyb staining in total embryos (ATG
MO 0 ng [124 embryos]; ATG MO 4 ng [75 embryos]; ATG MO 6 ng [66 embryos]; SP MO 0 ng [97 embryos]; SP MO 4 ng [49 embryos]; SP MO
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Error bars represent SEM. *p < 0.05; ***p < 0.001 (two-tailed unpaired Student’s t test).
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Expression
(A) Representative flow cytometric plots of CD31+c-KIT+ and
CD31+c-KIT+SCA1+ cell populations in the AGM after 4 days of cul-
ture with 20 mM psychosine.
(B and C) The average percentage of CD31+c-KIT+ (B) and CD31+c-
KIT+SCA1+ (C) cell populations with vehicle or psychosine treat-
ment (6 litters: control [n = 19 embryos]; psychosine [n = 20
embryos]).
(D and E) RT-PCR analysis of Gpr65, Gata2, and Runx1mRNA (D) and
Gata2 primary transcript (E) in FACS-sorted CD31+c-KIT cells (n = 3
independent experiments).
Error bars represent SEM. *p < 0.05; **p < 0.01; ***p < 0.001 (two-
tailed unpaired Student’s t test).Previously, we demonstrated that SetD8, the enzyme that
monomethylates H4K20 (Beck et al., 2012), repressesGata2
expression via the +9.5 site (DeVilbiss et al., 2015). We376 Stem Cell Reports j Vol. 6 j 368–382 j March 8, 2016 j ª2016 The Authotested the relevance of this mechanism to GPR65-mediated
Gata2 repression.We conducted quantitative ChIP analysis
for H4K20me1 in fetal liver cells (control or Gpr65 knock-
down) after culturing for 72 hr. Downregulating Gpr65
did not alter the SetD8 mRNA level (Figure 6K). Gpr65
downregulation reduced H4K20me1 at the +9.5 site (p =
0.002) and at sites 480 bp upstream (p = 0.002), 466 bp
downstream (p = 0.006), and 880 bp downstream (p =
0.02) of the +9.5 site (Figure 6K). H4K20me1 was unaltered
at the repressed muscle-specific MyoD promoter and the
constitutively active Eif3k promoter. These results support
a mechanism in which GPR65 represses Gata2 by
increasing a repressive chromatin mark at the +9.5 site.
The basic helix-loop-helix transcription factor Scl/TAL1 ac-
tivates Gata2 transcription through the +9.5 site, and Scl1/
TAL1 chromatin occupancy is reduced at the +9.5 site dur-
ing GATA-1-mediated Gata2 repression (Sanalkumar et al.,
2014). As Gpr65 downregulation decreased H4K20me1 at
the +9.5 site, this alteration may generate chromatin that
is more accessible to cognate binding factors. To determine
whether GPR65 alters GATA-1 and Scl/TAL1 occupancy, we
quantitated GATA-1 and Scl/TAL1 occupancy at the +9.5
site in fetal liver cells infected with control shRNA
or Gpr65 shRNA-expressing retrovirus. While knocking
down Gpr65 did not alter GATA-1 occupancy at the +9.5,
the knockdown increased Scl/TAL1 occupancy at the +9.5
1.6-fold (p = 0.02) but not at other target loci (Lyl1 and
Kit) (Figures 6K and S5). These results suggest that GPR65
represses Gata2 by establishing repressive chromatin that
limits Scl/TAL1 occupancy at the +9.5 site (Figure 6L).DISCUSSION
Genetic networks orchestrating stem and progenitor cell
transitions can be deconstructed into regulatory modules
termed network motifs (Alon, 2007; Shoval and Alon,
2010). Whereas major progress has been made to identify
individual genes controlling hematopoiesis (Gao et al.,
2013; Guo et al., 2013; Lara-Astiaso et al., 2014; Li et al.,
2014; Moignard et al., 2013; Solaimani Kartalaei et al.,
2015), many questions remain unanswered regarding
how the genes form network motifs, how the network mo-
tifs amalgamate into circuitry, and whether the circuitry
has an inherent plasticity and undergoes remodeling in
states of altered hematopoiesis such as stress, aging, and
malignancy.
Since the GATA-2-dependent genetic network promotes
hematopoiesis (Gao et al., 2013; Solaimani Kartalaei
et al., 2015), it is reasonable to infer that GATA-2-induced
factors are positive mediators of key steps, including
EHT, HSPC self-renewal, and differentiation. In erythroid
cells, GATA-1 activates heme biosynthetic genes, globinrs
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K
I
E
G
C
L
D
H
(legend on next page)
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subunits, and constituents of the red cell cytoskeleton
(Cheng et al., 2009; Fujiwara et al., 2009; Welch et al.,
2004; Yu et al., 2009), all required for erythroidmaturation.
Moreover, GATA-1 represses Gata2, Lyl1, and Kit (Grass
et al., 2003; Johnson et al., 2007; Munugalavadla et al.,
2005), to enable erythroid maturation. GATA-2 activates
Kit (Jing et al., 2008), an essential regulator of HSPCs (Heis-
sig et al., 2002; Huang et al., 1990), consistent with GATA-2
promoting HSPC genesis and function.
Using a coupled bioinformatics-experimental strategy,
we analyzed the large GPCR gene family to discover
GATA-2-induced GPCRs that promote HSPC transitions.
This analysis led to the surprising finding that GATA-2 ac-
tivates Gpr65 expression, which suppresses hematopoiesis
via negative feedback on Gata2. This negative feedback
mechanism conforms to a type I incoherent feedforward
loop (Mangan and Alon, 2003), which is defined as an
input (GATA-2) that elicits an output (EHT or hematopoie-
sis) through positive (increased Gpr65 expression) and
negative (GPR65 suppression of hematopoiesis) paths.
Type I incoherent feedforward loops shape the dynamics
of a mechanism, with the feedforward loop conferring a
pulse of activity to accelerate the reaction (Mangan and
Alon, 2003). Since the constituents and network motifs
governing HSPC transitions are still being identified, the
dynamics of steps in these transitions are largely unex-
plored. The mechanism of GPR65-mediated Gata2 repres-
sion involved elevation of a repressive histone mark,Figure 6. GPR65 Enhances H4K20me1 and Limits Scl/TAL1 Occup
(A) Representative flow cytometric plots of erythroid maturation base
average percentage of cells in R1 through R5 populations after infe
independent experiments).
(B) RT-PCR analysis of Gpr65mRNA in fetal liver cells (n = 5 independe
right), and quantification of GPR65 and a-tubulin intensities by den
(C) RT-PCR analysis of Gata2 mRNA and primary transcript in total fet
(D) Western blot of GATA-2 in fetal liver cells (top) and quantificati
experiments) (bottom).
(E) RT-PCR analysis of GATA-2 target gene expression in fetal liver ce
(F–I) Real-time RT-PCR analysis of Gpr65mRNA (F), Gata2mRNA (G), G
R2 cells (n = 3 independent experiments) (I). Western blot of GATA-2 i
a-tubulin band by densitometric analysis (n = 4 independent experim
(J) Fetal liver HSPCs were isolated from E14.5 embryos heterozygous fo
and expanded for 3 days (left). Allele-specific real-time RT-PCR analys
total fetal liver cells (n = 3 independent experiments) (middle) and F
(K) RT-PCR analysis of Setd8 mRNA in fetal liver cells treated with co
H4K20me1, GATA-1, and Scl/TAL1 chromatin occupancy measured by
treated with control or Gpr65 shRNA (H4K20me1: n = 8 independent ex
independent experiments) (right). H4K20me1 levels at the repressed M
chromatin occupancy 114 kb upstream from the c-Kit promoter and L
highest value obtained with PI antibody.
(L) GATA-2, a positive regulator of hematopoiesis, upregulates Gpr65,w
emergence. GPR65 represses Gata2 expression by increasing H4K20m
Error bars represent SEM. *p < 0.05; **p < 0.01; ***p < 0.001 (two-t
378 Stem Cell Reports j Vol. 6 j 368–382 j March 8, 2016 j ª2016 The AuthoH4K20me1, linked to reduced occupancy by the activator
Scl/TAL1. GPR65might directly target chromatin to restrict
Scl/TAL1 occupancy or might reduce Scl/TAL1 occupancy
prior to chromatin modification. Regardless of the order
of events, our analysis established a GATA factor-GPCR-
dependent type I incoherent feedforward loop that sup-
presses, rather than promotes hematopoiesis.
Gpr65, or T cell death-associated gene 8 (Tdag8), is a pro-
ton/acid-activated GPCR (Choi et al., 1996; Wang et al.,
2004). Whereas GPR65 had not been linked to HSPC tran-
sitions, it was reported to be a pro-apoptotic factor in gluco-
corticoid-induced lymphocyte apoptosis (Malone et al.,
2004) and to regulate cytokine production from macro-
phages (Mogi et al., 2009). Targeted deletion of Gpr65
revealed it was dispensable for glucocorticoid-induced
thymocyte apoptosis (Radu et al., 2006). These results
were suggested to reflect redundancy with related pH-
sensing GPCRs, which would create an obstacle to dissect
Gpr65 function in vivo. Although the impact of the pH-
sensing mechanism to GATA-2 function in the AGM and
fetal liver is unclear, the endogenous GPR65 antagonist
psychosine resembled Gpr65 shRNA in upregulating
Gata2 expression and hematopoiesis.
As GPR65 suppressedHSPC generation frommouse AGM
explants, it is instructive to consider the consequences of
ablating this mechanism in vivo. Abrogation of the mech-
anism would promote HSPC genesis and function. Since
ablating Gpr65 would be expected to increase HSPCs,ancy at the +9.5 Enhancer
d on CD71 and Ter119 expression 3 days after HSPC expansion. The
ction with control or Gpr65 shRNA is depicted on the right (n = 3
nt experiments) (left). Western blot of GPR65 in fetal liver cells (top
sitometry (n = 8 independent experiments) (bottom right).
al liver cells (n = 5 independent experiments).
on of GATA-2/a-tubulin ratio by densitometry (n = 6 independent
lls (n = 5 independent experiments).
ata2 primary transcript (G), and GATA-2 target genes in FACS-sorted
n FACS-sorted R2 cells and quantification of intensities of GATA-2 to
ents) (H).
r the +9.5 site at Gata2. Cells were infected with control or shGpr65
is of Gata2 transcripts from the wild-type and mutant +9.5 alleles in
ACS-sorted R2 cells (n = 3 independent experiments) (right).
ntrol or Gpr65 shRNA (n = 5 independent experiments) (top left).
quantitative ChIP at the +9.5 site in expanding fetal liver HSPCs
periments; GATA-1: n = 4 independent experiments; Scl/TAL1: n = 6
yoD promoter and the active Eif3k promoter (middle left). Scl/TAL1
yl1 exon1 as controls (bottom left). The dashed line illustrates the
hich encodes a negative regulator of hematopoiesis, to control HSC
e1, which restricts +9.5 occupancy by the activator Scl/TAL1.
ailed unpaired Student’s t test).
rs
evaluating the role of the GATA-2-GPR65 circuit in vivo
will require a careful quantitative analysis. Considerations
of type I incoherent feedforward loops (Alon, 2007; Man-
gan and Alon, 2003) would infer an alteration of the dy-
namics of specific steps of hematopoiesis, which might
not be evident from steady-state analyses. It is attractive
to propose that this suppressive mechanism is vital when
the demand for hematopoiesis increases, e.g. during stress,
since an unopposed increase could yield deleterious blood
cell elevations.
In summary, we discovered that GATA-2 activity to pro-
mote hematopoiesis involves induction of both positive
and negative mediators, the balance of which establishes
the physiological output. Based on the GPR65 pH-sensing
function, it will be crucial to analyze the pHmicroenviron-
ment of the AGM and other sites of hematopoiesis and to
establish the role of GPR65 as a mediator of pH-dependent
HSPC transitions.EXPERIMENTAL PROCEDURES
Mice and Embryo Generation
Gata2 +9.5-mutant mice were described by Johnson et al. (2012).
Pregnant females were euthanized with CO2, and freshly isolated
embryos were transferred into cold PBS for dissection. Animal ex-
periments were carried outwith ethical approval of the Association
for the Assessment and Accreditation of Laboratory Animal Care at
the University of Wisconsin-Madison.
AGM Explant Culture
AGMs were dissected from E11.5 embryos. AGMs were infected
(see below) and cultured as described by Gao et al. (2013).
Intact AGMs were cultured for 4 days on Durapore filters (Milli-
pore) at the air-liquid interface in IMDM+ (Iscove’s modified Dul-
becco’s medium) (Gibco) supplemented with 20% fetal bovine
serum (FBS; Gemini), 4 mM L-glutamine (Gibco), 1% penicillin/
streptomycin (Cellgro), 0.1 mM mercaptoethanol, 100 ng/ml
interleukin-3 (R&D Systems), 100 ng/ml Flt3L (R&D), and 1.5%
conditioned medium from a Kit ligand-producing Chinese ham-
ster ovary cell line.
Retroviral Infection
Detailed methodology is presented in Supplemental Experimental
Procedures. Gpr65 shRNA were cloned into the MSCV-PIG (IRES-
GFP) vector (kindly provided by Dr. Mitchell Weiss) (McIver et al.,
2014) using BglII and XhoI restriction sites. Retroviral expression
vectors for Gata2 and shLuc were described by Katsumura et al.
(2014). Retroviruses were packaged by co-transfecting 293T cells
with pCL-Eco packaging vector. Retroviral supernatant was
collected 24 and 48 hr post transfection and centrifuged to remove
cells anddebris. TheRetro-XConcentrator (Clontech#631455)was
used to concentrate retrovirus. E11.5 AGMs were infected with
20 ml concentrated retrovirus and 8 mg/ml polybrene in 500 ml
explant culture media at 1,200 3 g for 90 min at 30C. AGMs
were subjected to explant culture. Primary erythroid precursorsStemwere spinfectedwith100 ml retrovirus supernatant and8mg/ml pol-
ybrene in 400 ml fetal liver expansion medium at 1,200 3 g for
90 min at 30C. After centrifugation, 500 ml pre-warmed fetal liver
expansionmediumwas added, and cells were incubated at 37C for
72 hr. Details for concentrating retrovirus and Gpr65 shRNA se-
quences are available in Supplemental Experimental Procedures.
Flow Cytometry
Detailed methodology is presented in Supplemental Experimental
Procedures.
ChIP Assay
Detailed methodology is presented in Supplemental Experimental
Procedures.
Zebrafish Morpholino Knockdown
Detailed methodology is presented in Supplemental Experimental
Procedures.
Statistical Analysis
Student’s t tests were conducted using GraphPad Software or
Microsoft Excel. p Values in all figures are denoted by asterisks:
*p < 0.05, **p < .01, and ***p < .001.
ACCESSION NUMBERS
The accession number for GATA-2, RUNX1, and FLI1 ChIP-seq in
human CD34+ cells reported in the paper is GEO: GSE45144. The
accession number for GATA-2 and TAL1 ChIP-seq in HPC7 cells re-
ported in the paper is GEO: GSE22178. The accession number for
GATA-2 ChIP-seq in Lin BM cells reported in the paper is GEO:
GSM641911. The accession number for GATA-2 ChIP-seq in G1E
cells reported in the paper is GEO: GSM722387.
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Supplemental Information includes Supplemental Experimental
Procedures and five figures and can be found with this article on-
line at http://dx.doi.org/10.1016/j.stemcr.2016.01.008.
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